Phase 3 Study of Plozasiran in Adults With Hypertriglyceridemia

NCT06347133 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

1456

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertriglyceridemia

Interventions

DRUG: Plozasiran Injection
DRUG: Placebo

Sponsor

Arrowhead Pharmaceuticals